Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNiagen Bioscience Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.05 | $0.09 | $0.07 |
| Q2 2026 | 3 | -$0.02 | $0.04 | $0.02 |
| Q3 2026 | 3 | $0.03 | $0.08 | $0.06 |
| Q4 2026 | 1 | $0.07 | $0.08 | $0.08 |
| Q1 2027 | 1 | $0.05 | $0.06 | $0.06 |
| Q2 2027 | 1 | $0.05 | $0.05 | $0.05 |
| Q3 2027 | 1 | $0.07 | $0.08 | $0.08 |
| Q4 2027 | 1 | $0.11 | $0.13 | $0.12 |
| Q1 2028 | 1 | $0.08 | $0.10 | $0.09 |
| Q2 2028 | 1 | $0.06 | $0.07 | $0.07 |
| Q3 2028 | 1 | $0.10 | $0.12 | $0.11 |
| Q4 2028 | 1 | $0.15 | $0.17 | $0.16 |
Niagen Bioscience Inc. Earnings Date And Information
Niagen Bioscience Inc. last posted its earnings results on Wednesday, May 6th, 2026. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.01. The company had revenue of 31.47 M for the quarter and had revenue of 129.42 M for the year. Niagen Bioscience Inc. has generated $0 earnings per share over the last year ($0.2 diluted earnings per share) and currently has a price-to-earnings ratio of 14.49. Niagen Bioscience Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Niagen Bioscience Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/30/2026 | Q1 2026 | N/A | $0.08 | N/A | $31.03 M | $31.47 M |
| 12/30/2025 | Q4 2025 | N/A | $0.05 | N/A | $31.70 M | $33.84 M |
| 09/29/2025 | Q3 2025 | N/A | $0.06 | N/A | $31.20 M | $33.99 M |
| 06/30/2025 | Q2 2025 | N/A | $0.05 | N/A | $28.31 M | $31.12 M |
| 03/31/2025 | Q1 2025 | N/A | $0.07 | N/A | $27.08 M | $30.48 M |
| 12/31/2024 | Q4 2024 | N/A | $0.09 | N/A | $26.78 M | $29.13 M |
| 09/30/2024 | Q3 2024 | N/A | $0.02 | N/A | $24.03 M | $25.58 M |
| 06/30/2024 | Q2 2024 | -$0.02 | -$0.00 | 0.02 | $23.33 M | $22.74 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.01 | N/A | $23.48 M | $22.15 M |
| 12/31/2023 | Q4 2023 | N/A | $0.00 | N/A | N/A | $21.20 M |
| 09/30/2023 | Q3 2023 | N/A | -$0.01 | N/A | N/A | $19.50 M |
| 06/30/2023 | Q2 2023 | N/A | -$0.03 | N/A | N/A | $20.32 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.03 | N/A | N/A | $22.56 M |
| 12/31/2022 | Q4 2022 | N/A | -$0.02 | N/A | N/A | $21.00 M |
| 09/30/2022 | Q3 2022 | N/A | -$0.01 | N/A | N/A | $17.06 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.09 | N/A | N/A | $16.73 M |
| 03/31/2022 | Q1 2022 | N/A | -$0.11 | N/A | N/A | $17.26 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.08 | N/A | N/A | $17.76 M |
| 09/30/2021 | Q3 2021 | N/A | -$0.13 | N/A | N/A | $17.31 M |
| 06/30/2021 | Q2 2021 | N/A | -$0.08 | N/A | N/A | $17.70 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Niagen Bioscience Inc. Earnings: FAQ's
In the previous quarter, Niagen Bioscience Inc. (:NAGE) reported $0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $0.06 by $0.01.
The conference call for Niagen Bioscience Inc.'s latest earnings report can be listened to online.
The conference call transcript for Niagen Bioscience Inc.'s latest earnings report can be read online.
Niagen Bioscience Inc. (:NAGE) has a recorded annual revenue of $129.42 M.
Niagen Bioscience Inc. (:NAGE) has a recorded net income of $17.38 M.Niagen Bioscience Inc. has generated $0.22 earnings per share over the last four quarters.
Niagen Bioscience Inc. (:NAGE) has a price-to-earnings ratio of 14.49 and price/earnings-to-growth ratio is 0.52.